Prof. Stacy A. Kahn, MD, (University of Chicago School of Medicine, Comer Children's Hospital) recently delivered a lecture on Fecal Microbiota Transplantation (FMT): Ethical Challenges and Regulatory Hurdles. Dr. Kahn, a pediatrician, discussed the real-world challenges faced by clinicians whose patients see FMT as a magic bullet for the treatment of Inflammatory Bowel Diseases (IBD), despite a lack of evidence that it works for those conditions. She reviewed the differences between Clostridium difficile, for which FMT has been proven effective, and other digestive diseases, and provided an overview of ethical and regulatory issues presented by FMT. A video of her entire talk, which was the second in a series of three on Microbiome Research & Microbiota Therapeutics, can be found here.